Alt
/content/dam/asset-migration/headshots/uk-doctor-headshots/UK_Oncology_Headshot_Dr_Tim_Robinson.jpg

Dr Tim Robinson

Dr Tim Robinson
Tim
Robinson
BMedSci (Hons) BMBS (Hons) PgDip (Onc) PhD FHEA MRCP (Onc), Consultant Senior Lecturer and Honorary Medical Oncologist

Languages spoken

English

Expert in

Breast Cancer, chemotherapy, immunotherapy and neoadjuvant treatment

Overview

Centres

Bristol
Bristol

300 Park Avenue, Aztec West, Bristol BS32 4SY

51.541807689358095, -2.5709663094294277
/uk/our-centres/bristol
+44 (0)1454 456500
mediahawkNumber4110 mhMobile

Dr Tim Robinson is a Consultant Senior Lecturer in Medical Oncology at the University of Bristol and an Honorary Consultant Medical Oncologist at University Hospitals Bristol and Weston NHS Foundation Trust specialising in breast cancer.  He practices in all areas of breast oncology but has a special interest in younger women with breast cancer, management of the side effects of treatment and in triple negative breast cancer (TNBC).  He is passionate about improving patient care and helping patients decide the best individual treatment for them.  He regularly gives talks for Breast Cancer Now for women with breast cancer to help them understand treatment options for both metastatic breast cancer and TNBC.

Dr Robinson completed his medical oncology clinical and academic training in Bristol.  He undertook a Cancer Research UK Clinical Fellowship and was awarded a PhD from Cardiff University examining the role of breast cancer stem cells in chemo-resistance and exploring novel therapeutic strategies.  He also undertook a postgraduate diploma in oncology from the Institute of Cancer Research (University of London).  He was the recipient of a Coltman’s Scholar Award from the San Antonio Breast Cancer Symposium, the world’s largest breast cancer meeting, for work on the gut microbiome and breast cancer, has multiple peer-reviewed publications and has presented widely at national and international conferences.

He is heavily involved in clinical trials as a principal and chief investigator mainly in TNBC and breast cancer survivorship trials.  He is a member of national collaborative research groups and was appointed to the National Cancer Institute Breast Cancer Precision Medicine Working group in 2022 and is a member of the NICE expert panel of breast oncologists.

Expertise and interests

Interests
  • Breast Cancer
  • Chemotherapy
  • Immunotherapy
  • Neoadjuvant treatment

Awards

  • Coltman’s Scholars Award 2020

Professional memberships

  • Association of Cancer Physicians
  • European Society of Medical Oncology
  • UK Breast Intergroup